Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2025-12-24 @ 3:01 PM
NCT ID:
NCT02599259
Eligibility Criteria:
Inclusion Criteria:
* Is male or female at least 18 years of age.
* Having a diagnosis of ischemic stroke.
* Has a score between 1 and 20 on the NIH Stroke Survey (NIHSS) at admission and upon enrollment at discharge from the index admission to the hospital or at first encounter in the outpatient stroke center.
* Is taking any one of the monitored drugs- Coumadin®, Pradaxa®, Xarelto® or Eliquis®.
* Is going home or to acute outpatient rehabilitation after discharge.
* Has sufficient capacity to provide consent or agree to assent.
* Has at least minimal mental capacity and motor skills.
Exclusion Criteria:
* Has poor fine motor skills, to preclude him/her from holding a pill steady in front of a camera.
* Has impaired visual or auditory faculties.
* Is being released to a nursing home, hospice or any other inpatient care facility.
* Has stable, therapeutic INRs on warfarin for at least one year.
* Has a mechanical mitral valve or left ventricular assist device.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02599259
Study Brief:
Protocol Section:
NCT02599259